Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erminio Bonizzoni

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Cancer Medicine|November 15, 2019
Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese"Nicola Di Renzo, Lorella Melillo, Fernando Porretto, et al.
European Heart Journal|September 6, 2006
Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stentsSimon J Corbett, John Cosgrave, Gloria Melzi, et al.
Annals of Surgery|July 22, 2006
The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgeryGaetano de Donato, Gualberto Gussoni, Gianmarco de Donato, et al.
The Lancet. Oncology|September 4, 2009
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind studyGiancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, et al.
JAMA|May 5, 2005
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsIoannis Iakovou, Thomas Schmidt, Erminio Bonizzoni, et al.
Circulation. Cardiovascular Interventions|May 6, 2010
Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein graftsAzeem Latib, Luca Ferri, Alfonso Ielasi, et al.
BMC Infectious Diseases|November 10, 2016
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE studyGiorgio Cioni, Pierluigi Viale, Stefania Frasson, et al.
Circulation|August 1, 2007
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatmentFlavio Airoldi, Antonio Colombo, Nuccia Morici, et al.
BMC Cancer|March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Bone Marrow Transplantation|April 30, 2020
Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter studyNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Cancer Medicine|November 15, 2019
Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese"Nicola Di Renzo, Lorella Melillo, Fernando Porretto, et al.
European Heart Journal|September 6, 2006
Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stentsSimon J Corbett, John Cosgrave, Gloria Melzi, et al.
Annals of Surgery|July 22, 2006
The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgeryGaetano de Donato, Gualberto Gussoni, Gianmarco de Donato, et al.
The Lancet. Oncology|September 4, 2009
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind studyGiancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, et al.
JAMA|May 5, 2005
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsIoannis Iakovou, Thomas Schmidt, Erminio Bonizzoni, et al.
Circulation. Cardiovascular Interventions|May 6, 2010
Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein graftsAzeem Latib, Luca Ferri, Alfonso Ielasi, et al.
BMC Infectious Diseases|November 10, 2016
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE studyGiorgio Cioni, Pierluigi Viale, Stefania Frasson, et al.
Circulation|August 1, 2007
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatmentFlavio Airoldi, Antonio Colombo, Nuccia Morici, et al.
BMC Cancer|March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Bone Marrow Transplantation|April 30, 2020
Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter studyNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
Pageof 9